Target intelligence / Profile preview

Cilia- and flagella-associated protein 298 (CFAP298)

Target
CFAP298
Molecular classification
Other (motile cilia protein, axonemal assembly factor)
01

Overview

Cilia- and flagella-associated protein 298 (CFAP298) is a cytosolic and nuclear protein encoded by the CFAP298 gene on chromosome 21q22.1. The protein is mainly involved in the assembly of axonemal dynein arms, regulating motile cilia function critical for correct ciliary movement and positioning, and thus planar cell polarity. Mutations in CFAP298 disrupt dynein arm assembly, leading to primary ciliary dyskinesia and related disorders. The protein is expressed in most tissues, except for relatively lower levels in the heart, liver, and certain brain regions, and has notable roles during early development. No small-molecule drugs or therapeutic agents are known to target CFAP298 directly. The gene’s altered expression is associated with prognosis in certain cancers (acute myeloid leukemia) and neurodegenerative disorders (Alzheimer's disease), but it is not considered a direct therapeutic target or classic receptor, enzyme, or transporter[1][2][3][5][9].

Other names
C21orf48C21orf59CILD26DNAAF16FBB18KurFLJ20467protein kurly homologUPF0769 protein C21orf59dynein axonemal assembly factor 16kurly homolog (zebrafish)prostate cancer upregulated protein 1
02

Biological functions

Cilium assemblyRegulation of ciliary motilityDynein arm assembly (axonemal complex)Planar cell polarity regulationSuppression of canonical Wnt signaling (possible)
03

Disease associations

CiliopathiesPrimary ciliary dyskinesiaVisceral heterotaxyAcute myeloid leukemia (biomarker association, not causation)Alzheimer's disease (expression association)Associated with Down syndrome critical region
04

Safety considerations

No direct safety concerns reported; mutations are linked to loss of ciliary motility and related congenital syndrome phenotypes
05

Biomarkers

Elevated in bone marrow of acute myeloid leukemia with poor prognosisDecreased in blood of male Alzheimer’s patients

Beyond the preview

Go deeper on Cilia- and flagella-associated protein 298 (CFAP298).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cilia- and flagella-associated protein 298 (CFAP298).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call